STI-1386

N/A

Report date: 2022/11/20 17:26:35

Base Information

Drug NameSTI-1386
Drug Alias NameSTI-1386
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsImmunologic cytotoxicity
TargetsNot applicable
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisPancreatic Neoplasms +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSorrento Therapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisPancreatic Neoplasms +[4
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A